3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...

3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025CStone Submits Clinical Trial Application in Australia for CS5001 in D...

3/5/2025CStone Announces First Patient Dosed in Global Trial of Trispecific An...

3/4/2025Hansoh Pharma's HS-20089 Advances to Phase III Trial for Platinum-Resi...

3/4/2025Longbio Pharma's LP-003 Shows Promising Results in Phase II CSU Trial

3/4/2025The United Labs' UBT251 Injection Receives FDA Approval for Phase II C...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

3/3/2025Innovent's IBI363 Enters Pivotal Trial, Challenging Keytruda in Melano...

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

Page:3/11 Total number of articles:316: [First][<<] [1] [2] [3] [4] [5] [>>] [End]